Warning Letter Roundup: Four Drug Facilities Draw Warnings for GMPs

The FDA issued warning letters to four drug manufacturing plants for failure to maintain good manufacturing practices — and to one firm for producing misbranded and unapproved drug products.
Source: Drug GMP Report